Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. - Wikidata - awgldk - TriplyDB

Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension.

Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension.

http://www.wikidata.org/entity/Q33329056

about

Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension The limits of oral therapy in pulmonary arterial hypertension management Pathobiology of pulmonary arterial hypertension and right ventricular failure Immune and inflammatory mechanisms in pulmonary arterial hypertension DNA Damage and Pulmonary Hypertension Early treatment with fumagillin, an inhibitor of methionine aminopeptidase-2, prevents Pulmonary Hypertension in monocrotaline-injured rats Sustained hypoxia promotes the development of a pulmonary artery-specific chronic inflammatory microenvironment Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease.Platelet-derived growth factor-A and vascular endothelial growth factor-C contribute to the development of pulmonary tumor thrombotic microangiopathy in gastric cancer.The cancer theory of pulmonary arterial hypertension.PK10453, a nonselective platelet-derived growth factor receptor inhibitor, prevents the progression of pulmonary arterial hypertension.Glycogen synthase kinase 3beta contributes to proliferation of arterial smooth muscle cells in pulmonary hypertension.Up-regulated lipocalin-2 in pulmonary hypertension involving in pulmonary artery SMC resistance to apoptosis.Egr-1 expression during neointimal development in flow-associated pulmonary hypertension.Pulmonary hypertension and metabolic syndrome: Possible connection, PPARγ and Caveolin-1 Targeting the PDGF signaling pathway in the treatment of non-malignant diseases.Cofilin, a hypoxia-regulated protein in murine lungs identified by 2DE: role of the cytoskeletal protein cofilin in pulmonary hypertension.Role for miR-204 in human pulmonary arterial hypertension Serotonin transporter interacts with the PDGFβ receptor in PDGF-BB-induced signaling and mitogenesis in pulmonary artery smooth muscle cells New perspectives for the treatment of pulmonary hypertension A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion.Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats.Evaluation of circulating proteins and hemodynamics towards predicting mortality in children with pulmonary arterial hypertension Mice lacking the Raf-1 kinase inhibitor protein exhibit exaggerated hypoxia-induced pulmonary hypertension.Platelet-derived growth factor receptor-β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive d Deficiency of Akt1, but not Akt2, attenuates the development of pulmonary hypertension.Effect of cocaine on human immunodeficiency virus-mediated pulmonary endothelial and smooth muscle dysfunction.Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling.Human immunodeficiency virus transgenic rats exhibit pulmonary hypertension Sex affects bone morphogenetic protein type II receptor signaling in pulmonary artery smooth muscle cells.Increased oxidative stress and severe arterial remodeling induced by permanent high-flow challenge in experimental pulmonary hypertension.Krüppel-like factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension.Progenitor cells in pulmonary vascular remodeling.Overview of current therapeutic approaches for pulmonary hypertension.Hypoxic pulmonary hypertension in mice with constitutively active platelet-derived growth factor receptor-β.Hyperplastic Growth of Pulmonary Artery Smooth Muscle Cells from Subjects with Pulmonary Arterial Hypertension Is Activated through JNK and p38 MAPK.Vascular involvement in systemic sclerosis (scleroderma).Na(+)/H(+) exchange and hypoxic pulmonary hypertension.Lack of inhibitory effects of the anti-fibrotic drug imatinib on endothelial cell functions in vitro and in vivo.PDGF enhances store-operated Ca2+ entry by upregulating STIM1/Orai1 via activation of Akt/mTOR in human pulmonary arterial smooth muscle cells.

P2860

Q24338499-4AEFA08B-1798-4785-9D93-AB721B49F896 Q26773209-8D5BFD2F-79CD-45DB-821D-B6718C78F31A Q26821779-DE9FC9C2-D03D-4B83-B606-745EE2BC61F2 Q26851508-A40EAE9A-7223-46F7-95F6-8CFB6A81ADAD Q27005594-748AC3FD-32D7-462A-A265-5AADAD43C3CD Q28730633-A2ED9AA8-B61C-4F8C-AE7C-F693C2AFAA66 Q29346986-6E3269DA-030C-46D0-92CC-4B02F24361E5 Q30945205-BC7F58F5-0ED3-4289-9AC7-D12FA3663399 Q33406697-3C63BAB1-C4FF-4069-8C25-BC442329EDD8 Q33788493-7BED2E3F-09E8-437A-A752-A55028953E7D Q33805920-8665B63D-F0BD-4FE8-AE4F-A28AC43AD067 Q33886299-1EB753D0-9728-4E7B-B70E-0AFDA907266D Q33970205-3AA784C0-3CE4-44C1-9714-D0D7F5A672CD Q34021089-2D0866D9-8731-44B6-A61A-748E2AF59D80 Q34178976-41DD50FA-7775-45FD-B2C1-ECEA270846CB Q34352802-4456F37B-DCD2-43BE-BA39-1CC1E6CA4AE5 Q34480694-1FC79583-CC8E-4F1D-987D-B0DCE2C361D9 Q34681312-259ABC83-2E06-44A3-918C-A4706190A6BF Q34720232-78448FDE-EDAD-44C1-A60B-24EDE3BC250D Q34903204-A2040E4A-7ED4-43BA-A61F-EDE2A31FF534 Q34914604-83BF4812-9265-437B-BAEA-6AB68A4BC915 Q35014605-FFC0E0FC-8D64-43DD-B94F-A4F33A38E9CE Q35053507-935E44A7-B8D5-41A8-8E8F-0B8A40A2FADD Q35089864-E0A94157-CE55-42F6-9B0E-3D0F959D4BCC Q35093008-141D4E62-781D-411B-92CB-A0DF57FFB8E2 Q35115837-AEAFC94F-72E9-46F3-8A43-5034C38112A9 Q35132178-6B816CD2-5C4E-4ABC-95DC-CEF47D7538B3 Q35184983-14EB117E-61A3-482F-B8F7-432C37C8D9FC Q35217383-90667E9E-2753-4A28-A17C-12FD7055A4DA Q35262038-079BCD5F-18ED-4256-89D7-A702A8D9FD9F Q35289907-1F106AB5-AE13-4F89-B2E3-9A62E9DE3259 Q35344650-B3BC237F-CF24-4991-B0A7-80C34F64ECDB Q35412268-9759F4F1-F113-4EF9-B09E-3C4E163BA634 Q35412362-7AB8AA97-3CBA-4A41-8B52-F9F4F2EB3C5B Q35412507-DE0A6C53-3FCD-40AD-8655-FEB04EA5D5AE Q35533008-16690431-85C4-4A80-B76E-FF6DACFCFCC8 Q35557424-C901075E-1AC5-48D0-BF0C-37F2C8996AE5 Q35665720-9C9DB973-2703-49A9-9E0A-0D154B600CF7 Q35832033-BA7887A0-2032-46A0-8803-FE37D4EAC478 Q35895524-F7F39E96-9953-4646-A116-D660A695BD1F

P2860

Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension.

http://www.wikidata.org/entity/Q33329056

description

2008 nî lūn-bûn

@nan

2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Platelet-derived growth factor ...... lmonary arterial hypertension.

@ast

Platelet-derived growth factor ...... lmonary arterial hypertension.

@en

Platelet-derived growth factor ...... lmonary arterial hypertension.

@nl

type

label

Platelet-derived growth factor ...... lmonary arterial hypertension.

@ast

Platelet-derived growth factor ...... lmonary arterial hypertension.

@en

Platelet-derived growth factor ...... lmonary arterial hypertension.

@nl

prefLabel

Platelet-derived growth factor ...... lmonary arterial hypertension.

@ast

Platelet-derived growth factor ...... lmonary arterial hypertension.

@en

Platelet-derived growth factor ...... lmonary arterial hypertension.

@nl

P1433

Q33329056-0EB3E5DA-9AC8-4E15-96E2-5D2A638AECF6

P1476

Q33329056-972A9B51-A025-4D3A-A372-7849B131F9D0

P2093

Q33329056-1433A902-8D47-47AF-9FCD-044615D3D677

Q33329056-47F77CB6-FEBC-4EBC-AAF0-0088F97ED24D

Q33329056-51526B3B-BC5E-4631-B5E2-BEFF523547AA

Q33329056-6BA68B70-9608-4B18-8021-42172988929A

Q33329056-75C72243-781C-4694-8DEE-171EC61377D2

Q33329056-831DEB39-AC5E-4F98-84C0-9D1CBA1B970C

Q33329056-928541A8-69D7-41F0-A5B7-320502DDFB35

Q33329056-E2C49933-6E72-40EA-8372-A5C5D308C289

Q33329056-F2AF31BD-92DE-44F0-A24D-37B86DB0E750

P304

Q33329056-0AE594A7-3F98-431B-927F-ECDAD02BE7AB

P31

Q33329056-E04D6FBF-B2CE-4B0C-A527-0276724EB6D2

P356

Q33329056-49A11432-D7D3-4742-B3AE-1D364422A4FC

P407

Q33329056-62CA6D96-D676-4982-BB3D-FD5A58C15EEA

P433

Q33329056-0755F144-0440-4BB8-9409-1D91B387CA10

P478

Q33329056-DB4D66FF-F998-4126-86EF-810CB2642C54

P50

Q33329056-1133B443-FD73-46B3-B836-A8336A06C045

Q33329056-2F862D95-B412-47EA-B44B-C8B7B4D6F291

Q33329056-B438610C-93B7-43BB-866A-25CA6B42BF66

Q33329056-B51BCB62-9172-406D-94D2-93781740646E

Q33329056-C9A0D9D6-D03F-41E0-8FF9-9E94F041C97A

Q33329056-CFE2C471-D46C-45E0-90BE-F3707FB82E3A

Q33329056-D65627F9-EEB0-464A-A1AF-9E3032D051AD

P577

Q33329056-59A6F071-1CC3-4356-A9DC-6C0D5239A3E0

P698

Q33329056-4C1FBF77-B625-4EF3-973D-C5232461BC99

P921

Q33329056-56374C64-A254-4409-B728-4140CDD1B581

Q33329056-7D7EC71A-DF53-4A2B-8404-6FF2D920D462

P356

RCCM.200707-1037OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Platelet-derived growth factor ...... lmonary arterial hypertension.

@en

P2093

Colas Tcherakian

http://www.w3.org/2001/XMLSchema#string

Dominique Emilie

http://www.w3.org/2001/XMLSchema#string

Elie Fadel

http://www.w3.org/2001/XMLSchema#string

Gérald Simonneau

http://www.w3.org/2001/XMLSchema#string

Ingrid Durand-Gasselin

http://www.w3.org/2001/XMLSchema#string

Michel Mazmanian

http://www.w3.org/2001/XMLSchema#string

Olaf Mercier

http://www.w3.org/2001/XMLSchema#string

Philippe Hervé

http://www.w3.org/2001/XMLSchema#string

Saadia Eddahibi

http://www.w3.org/2001/XMLSchema#string

P304

81-88

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.200707-1037OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

178

http://www.w3.org/2001/XMLSchema#string

P50

Peter Dorfmuller

Jérôme Le Pavec

Frédéric Perros

P577

2008-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18420966

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension